Foghorn Therapeutics (FHTX) Other Non Operating Income: 2020-2025
Historic Other Non Operating Income for Foghorn Therapeutics (FHTX) over the last 6 years, with Sep 2025 value amounting to $620,000.
- Foghorn Therapeutics' Other Non Operating Income fell 49.80% to $620,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 24.16%. This contributed to the annual value of $4.2 million for FY2024, which is 47.05% up from last year.
- Latest data reveals that Foghorn Therapeutics reported Other Non Operating Income of $620,000 as of Q3 2025, which was down 27.23% from $852,000 recorded in Q2 2025.
- Foghorn Therapeutics' Other Non Operating Income's 5-year high stood at $1.4 million during Q4 2024, with a 5-year trough of -$1.2 million in Q4 2021.
- Its 3-year average for Other Non Operating Income is $895,727, with a median of $739,000 in 2024.
- Over the last 5 years, Foghorn Therapeutics' Other Non Operating Income had its largest YoY gain of 4,507.14% in 2021, and its largest YoY loss of 312.77% in 2021.
- Quarterly analysis of 5 years shows Foghorn Therapeutics' Other Non Operating Income stood at -$1.2 million in 2021, then surged by 152.00% to $624,000 in 2022, then climbed by 8.65% to $678,000 in 2023, then surged by 107.37% to $1.4 million in 2024, then tumbled by 49.80% to $620,000 in 2025.
- Its Other Non Operating Income stands at $620,000 for Q3 2025, versus $852,000 for Q2 2025 and $1.4 million for Q1 2025.